TCRT Announces Positive Preclinical Data for ALN1003 Obesity Drug, Shows 12.9% Weight Loss, Liver Reduction
Alaunos Therapeutics, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $2.87
-14% since the alert
$3.32 → $2.87
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS